Circadian variation in intestine toxicity of Mycophenolate mofetil in rats: an experimental and histopathologic study

References

• Allison AC, Eugui EM. 2000. Mycophenolate mofetil and its mechanisms of action. Immunopharmacology. 47(2–3):85–118.
   PubMed Web of Science ®Google Scholar
• Allison AC, Eugui EM. 2005. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation. 80:S181–S190.
   PubMed Web of Science ®Google Scholar
• Anderson JM, Van Itallie CM. 1995. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol Gastointest Liver Physiol. 269:467–475.
   PubMed Web of Science ®Google Scholar
• Apostolov R, Asadi K, Lokan J, Kam N, Testro A. 2017 Feb 24. Mycophenolate mofetil toxicity mimicking acute cellular rejection in a small intestinal transplant. World J Transplant. 7(1): 98–102.
   PubMedGoogle Scholar
• Arns W. 2007 Jan-Feb. Noninfectious gastrointestinal (GI) complications of mycophenolic acid therapy: a consequence of local GI toxicity? Transplant Proc. 39(1): 88–93. Review.
   PubMed Web of Science ®Google Scholar
• Behling KC, Foster DMJ, Edmonston TB. 2009. Witkiewicz AK: graft-versus-host disease-like pattern in mycophenolate mofetil related colon mucosal injury: role of FISH in establishing the diagnosis. Case Rep Gastroenterol. 3:418–423.
   PubMedGoogle Scholar
• Ben-Cherif W, Dridi I, Aouam K, Ben-Attia M, Reinberg A, Boughattas NA. 2014. Circadian variation of valproic acid pharmacokinetics in mice. Eur J Pharm Sci. 49:468–473.
   Web of Science ®Google Scholar
• Ben-Cherif W, Dridi I, Haouas Z, Miled A, Aouam K, Ben-Attia M. 2015. Reinberg A and Boughattas NA. Circadian time-dependent hepatic and renal toxicities to valproic acid in mice. Biol Rhythm Res. 46(6).
   Web of Science ®Google Scholar
• Berribi C, Loirat C, Jacqz-Aigrain E. 2000. Mycophenolate mofetil may induce apoptosis in duodenal villi. Pediatr Nephrol. 14:177–178.
   PubMed Web of Science ®Google Scholar
• Blikslager AT, Moeser AJ, Gookin JL, Jones SL, Odle J. 2007. Restoration of barrier function in injured intestinal mucosa. Physiol Rev. 87:545–564.
   PubMed Web of Science ®Google Scholar
• Boughattas NA, Li XM, Filipski J, Lemaigre G, Filipski E, Bouzouita K, Belhadj O, Lévi F. 1996 Jul. Modulation of cisplatin chronotoxicity related to reduced glutathione in mice. Hum Exp Toxicol. 15(7):563–572.
   PubMed Web of Science ®Google Scholar
• Childers R, Chow G, Fraig M, Asamoah V, Wong P. 2011. Education and imaging. Gastrointestinal: chronic CellCept-induced colitis. J Gastroenterol Hepatol. 26:1214.
   PubMedGoogle Scholar
• Christians U, Klawitter J, Klawitter J, Brunner N, Schmitz V. 2011 Feb. Biomarkers of immunosuppressant organ toxicity after transplantation: status, concepts and misconceptions. Expert Opin Drug Metab Toxicol. 7(2):175–200.
   PubMed Web of Science ®Google Scholar
• Dridi I, Ben-Cherif W, Aouam K, Ben-Attia M, Klouz A, Reinberg A, Boughattas NA. 2014. Circadian variation of mycophenolate mofetil pharmacokinetics in rats. EurJ Pharm. 58:20–25.
   Google Scholar
• Dridi I, Ben-Cherif W, Aouam K, Hassine M, Ben-Attia M, Reinberg A, Boughattas NA. 2013. Circadian variation in haematological toxicity of the immunosuppressive agent “mycophenolate mofetil” in rats. J Appl Biomed. 11:71–78.
   Web of Science ®Google Scholar
• Ducloux D, Ottignon Y, Semhoun-Ducloux S, Labbé S, Saint-Hillier Y, Miguet JP, Carayon P, Chalopin JM. 1998 Oct 27. Mycophenolate mofetil-induced villous atrophy. Transplantation. 66(8): 1115–1116.
   PubMed Web of Science ®Google Scholar
• Dumortier J, Gagnieu MC, Salandre J, Guillaud O, Guillem P, Adham M, Boillot O. 2006. Conversion from mycophenolate mofetil to enteric-coated myco-phenolate sodium in liver transplant patients presenting gastrointestinal disorders: A pilot study. Liver Transpl. 12:1342–1346.
   PubMed Web of Science ®Google Scholar
• Epinette WW, Parker CM, Jones EL, Greist MC1987. Mycophenolic acid for psoriasis. A review of pharmacology, long-term efficacy, and safety. J Am Acad Dermatol. 17:962–971.
   PubMed Web of Science ®Google Scholar
• Gautam R, Singh M, Gautam S, Rawat JK, Saraf SA, Kaithwas G. 2016 Mar. Rutin attenuates intestinal toxicity induced by Methotrexate linked with anti-oxidative and anti-inflammatory effects. BMC Complement Altern Med. 10(16):99.
   Google Scholar
• Guada M, Beloqui A, Alhouayek M, Muccioli GG, Dios-Viéitez Mdel C, Préat V, Blanco-Prieto MJ. 2016 Apr 30. Cyclosporine A-loaded lipid nanoparticles in inflammatory bowel disease. Int J Pharm. 503(1–2): 196–198.
   PubMedGoogle Scholar
• Hassard PV, Vasiliauskas EA, Kam LY, Targan SR, Abreu MT. 2000. Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn’s disease. Inflamm Bowel Dis. 6:16–20.
   PubMed Web of Science ®Google Scholar
• Inoue H, Sugioka N, Hayashida K, Yasumura T. 1997. Pharmacokinetic studies of mycophenolate mofetil in rat kidney allograft recipients. Int J Urol. 4:279–284.
   PubMedGoogle Scholar
• Khan MR, Siddiqui S, Parveen K, Javed S, Diwakar S, Siddiqui WA. 2010. Nephroprotective action of tocotrienol-rich fraction (TRF) from palm oil against potassium dichromate (K2Cr2O7)-induced acute renal injury in rats. Chem Biol Interact. 186:228–238.
   PubMed Web of Science ®Google Scholar
• Khedhaier A, Ben-Attia M, Gadacha W, Sani M, Bouzouita K, Chouchane L, Mechkouri M, Reinberg A, Boughattas NA. 2003. Circadian rhythms in toxic effects of the serotonin antagonistondansetron in mice. Chronobiol Int. 20:1103–1116.
   PubMed Web of Science ®Google Scholar
• Khoury N, Ammor M, Durrbach A, Kriaa F, Charpentier B. 2000. Diffuse colitis associated with mycophenolate mofetil treatment: apropos of 1 case. Nephrologie. 21(8):437–439. French.
   PubMedGoogle Scholar
• Liu YL, Huang JJ, Hou YQ, Zhu H, Zhao S, Ding B, Yin Y, Yi G, Shi J, Fan W. 2008. Dietary arginine supplementation alleviates intestinal mucosal disruption induced by Escherichia coli lipopolysaccharide in weaned pigs. Br J Nutr. 100(3):552–560.
   PubMed Web of Science ®Google Scholar
• LoGuidice A, Wallace BD, Bendel L, Redinbo MR, Boelsterli UA. 2012 May. Pharmacologic targeting of bacterial β-glucuronidase alleviates nonsteroidal anti-inflammatory drug-induced enteropathy in mice. J Pharmacol Exp Ther. 341(2):447–454.
   PubMed Web of Science ®Google Scholar
• Lv QK, Liu JX, Li SN, Gao YJ, Lv Y, Xu ZP, Huang BX, Xu SY, Yang DX, Zeng YL, et al. 2015 Nov 6. Mycophenolate mofetil modulates differentiation of Th1/Th2 and the secretion of cytokines in an active Crohn’s disease mouse model. Int J Mol Sci. 16(11): 26654–26666.
   PubMed Web of Science ®Google Scholar
• Neerman MF, Boothe DM. 2003 Jun. A possible mechanism of gastrointestinal toxicity posed by mycophenolic acid. Pharmacol Res. 47(6):523–526.
   PubMed Web of Science ®Google Scholar
• Nelson W, Tong YL, Lee JK, Halberg F. 1979. Methods for cosinor-rhythmometry. Chronobiologia. 6:305–323.
   PubMedGoogle Scholar
• Nguyen H, Le C, Nguyen H. 2009. Gastric antral vascular ectasia (watermelon stomach) – an enigmatic and often-overlooked cause of gastrointestinal bleeding in the elderly. Perm J Fall. 13:46–49.
   PubMedGoogle Scholar
• Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ. 1999. Mycophenolate mofetil in autoimmune and inflammatory skin disorders. J Am Acad Dermatol. 40:265–268.
   PubMed Web of Science ®Google Scholar
• Olyaei AJ, de Mattos AM, Bennett WM. 1998. Pharmacology of immunosuppressive drugs. Drugs Today (Barc). 34:463–479.
   PubMed Web of Science ®Google Scholar
• Papadimitriou JC, Cangro CB, Lustberg A, Khaled A, Nogueira J, Wiland A, Ramos E, Klassen DK, Drachenberg CB. 2003 Oct. Histologic features of mycophenolate mofetil-related colitis: a graft-versus-host disease-like pattern. Int J Surg Pathol. 11(4):295–302.
   PubMed Web of Science ®Google Scholar
• Pusztaszeri M, Girardin M, Hadengue A, Rubbia-Brandt L, Genevay M. 2010 Sep 8. Drug-induced injury in the gastrointestinal tract: a clinico-pathological review. Rev Med Suisse. 6(261): 1650–1655.
   PubMedGoogle Scholar
• Ruan Z, Liu S, Zhou Y, Mi S, Liu G, Wu X, Yao K, Assaad H, Deng Z, Hou Y, et al. 2014 Jun 2. Chlorogenic acid decreases intestinal permeability and increases expression of intestinal tight junction proteins in weaned rats challenged with LPS. PLoS One. 9(6): e97815.
   PubMed Web of Science ®Google Scholar
• Selbst MK, Ahrens WA, Robert ME, Friedman A, Proctor DD, Jain D. 2009 Jun. Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil. Mod Pathol. 22(6):737–743.
   PubMed Web of Science ®Google Scholar
• Sheikhzadeh S, Malekinejad H, Hobbenaghi R. 2013 Spring. Mycophenolate mofetil alters the antioxidant status in duodenum of rats: implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders. Vet Res Forum. 4 (2): 77–83.
   PubMedGoogle Scholar
• Siconolfi L. 1996 Aug. Mycophenolate mofetil (CellCept): immunosuppression on the cutting edge. AACN Clin Issues. 7(3):390–402.
   PubMedGoogle Scholar
• Simmons WD, Rayhill SC, Sollinger HW. 1997 Aug. Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection. Drug Saf. 17(2):75–92.
   PubMed Web of Science ®Google Scholar
• Strober W, Fuss IJ, Blumberg RS. 2002. The immunology of mucosal models of inflammation 1. Annu Rev Immunol. 20:495–549.
   PubMed Web of Science ®Google Scholar
• Tierce JC, Porterfield-Baxa J, Petrilla AA, Kilburg A, Ferguson RM. 2005. Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients. Clin transplant. 19(6):779–784.
   PubMed Web of Science ®Google Scholar
• Touitou Y, Smolensky MH, Portaluppi F. 2008. Ethics, standards, and procedures in human and animal in chronobiology researching. Chronobiol Int. 25:851–867.
   PubMed Web of Science ®Google Scholar
• Weclawiak H, Ould-Mohamed A, Bournet B, Guilbeau-Frugier C, Fortenfant F, Muscari F, Sallusto F, Dambrin C, Esposito L, Guitard J, et al. 2011. Duodenal villous atrophy: a cause of chronic diarrhea after solid-organ transplantation. Am J Transplant. 11:575–582.
   PubMed Web of Science ®Google Scholar
• Yang CM, Ferket PR, Hong QH, Zhou J, Cao GT, Zhou L, Chen AG. 2012. Effect of chito-oligosaccharide on growth performance, intestinal barrier function, intestinal morphology and cecal microflora in weaned pigs. J Anim Sci. 90(8):2671–2676.
   PubMed Web of Science ®Google Scholar